Interface News Reporter Zhang Yi

Wind statistics show that in July, a total of 219 companies faced the lifting of the ban on restricted shares, with a total of 19.811 billion new tradable shares, calculated at the latest closing price (the same below), which is about 284.174 billion yuan in market value. The market value of the ban has been in the middle this year.

the peak of lifting the ban this month is in the fourth week (July 22-26), and the scale of lifting the ban this week is nearly 100 billion yuan.

Charting: Interface News Securities Group

there are two companies with a market value of more than 10 billion yuan lifted this month, namely daquan energy (688303.SH) and sansheng guojian (688336.SH), both of which are science and technology board companies and the first restricted shares were lifted. Baiyang Pharmaceuticals (301015.SZ) was second, with a market value of more than 9 billion yuan. Tax Friends (603171.SH), Jinbo Bio (832982.BJ) and Runfeng (301035.SZ) have a market value of more than 8 billion yuan.

Charting: Interface News Securities Group

Daquan Energy is one of the high-purity polysilicon manufacturers. In July, it will usher in the lifting of the ban on the first three-year listing of A- shares. The company's recent share price has fallen to a new low since its listing. The company's offering price was 21.49 yuan per share, which rose to 96 yuan per share at the initial stage of listing, but the latest closing price has fallen to 20.39 yuan per share, with the latest market capitalization of 43.7 billion yuan.

With the lifting of the ban approaching, Xu Guangfu, the actual controller and chairman of Daquan Energy, voluntarily promised not to reduce his direct holdings of the company's shares in any way within 6 months from July 23, 2024. It is intended to recognize the confidence and long-term value of the company's future development prospects. However, for the identity of the actual controller, only half a year's commitment not to reduce holdings is not long, and the sincerity is limited, which also means that there is uncertainty about whether to reduce holdings after half a year.

and, promised not to reduce the number of shares held by Xu Guangfu "directly", its direct stake in Daquan Energy is only 19.5 million shares, accounting for 0.91 of the total share capital, about market value of 0.398 billion yuan. The remaining shareholders more than the proportion of the lifting of the ban did not reduce the commitment.

details of the lifting of the ban on restricted shares of Daquan Energy this month

Specifically this week, the scale of the lifting of the ban is medium. Wind statistics show that a total of 62 companies lifted the ban on restricted shares this week, with 4.379 billion shares lifted and a market value of 67.472 billion yuan.

there are 14 companies with a market value of more than 1 billion yuan lifted this week. the top three companies are baiyang medicine, tax friends shares and Hangzhou thermal power (605011.SH), with a market value of more than 6 billion yuan lifted.

there are 11 companies with more than 0.1 billion shares lifted, with the top three being xinke mobile-U(688387.SH), baiyang medicine and weigao orthopedics (688161.SH).

Charting: Interface News Securities Group

According to the announcement, on July 3, Baiyang Pharmaceutical had 0.407 billion initial restricted shares listed for circulation, accounting for 77.38 of the total share capital. The company's circulation increased by more than 300, or about 9.57 billion yuan in market value.

Baiyang Pharmaceutical is a company engaged in pharmaceutical distribution and retail business. Since its listing, the company's performance has maintained positive growth. In the first quarter of this year, revenue growth was weak for the first time, falling slightly by 1.50 to 1.661 billion yuan, but its net profit attributable to its parent still increased by 35.60 to 0.166 billion yuan year-on-year.

recently, baiyang pharmaceutical disclosed that it plans to acquire the assets of controlling shareholder baiyang pharmaceutical group for 0.88 billion yuan, thus controlling 60.20 percent of baiyang pharmaceutical. However, the acquisition has a high appreciation rate and low performance commitment, and even forecast a decline in net profit in 2027, which the exchange questions whether there is a situation of transferring benefits to counterparties through inflated valuations.

Baiyang Pharmaceutical's share price fell about 25% during June. The company's latest share price is 23.53 yuan/share, still up 200 from the issue price of 7.64 yuan/share.

This is the lifting of the ban on the sale of shares within the three-year period of the listing of Baiyang Pharmaceutical. The lifting of the ban involves a total of 6 shareholders, including the largest shareholder Baiyang Pharmaceutical Group Co., Ltd., Beijing Baiyang Chengchuang Pharmaceutical Investment Co., Ltd., and 4 asset management companies. All are persons acting in concert. These shareholders have earned a book float of about 6.5 billion yuan since the stock price rose.

details of the lifting of the ban on the restricted shares of baiyang medicine

according to the announcement, 0.315 billion shares of tax friends were lifted on July 1, accounting for 77.46 per cent of the total share capital, and the circulation also increased by more than 300 per cent, or about a market value of 8.528 billion yuan.

The ban was lifted by two persons, namely the controlling shareholder Ningbo Sichi Venture Capital Partnership (Limited Partnership) and the actual controller, chairman and general manager Zhang Zhenchao. Zhang Zhenchao promised not to reduce his direct shares in the company for 12 months from July 1, 2024.

Tax Friends is a company engaged in tax information business. The company has been listed for three years and its performance has declined for three years, with net profit of 0.231 billion yuan, 0.144 billion yuan and 0.083 billion yuan from 2021 to 2023, respectively, compared with -23.64 percent, -37.64 percent and -42.05 percent year-on-year.

last week, the share price of tax friends showed a change, with three consecutive trading boards. The company said that there is no material information that should be disclosed but not disclosed, and there is no material matter in the planning stage. On the most recent trading day, the company's share price fell 6.50 percent to close at 27.04 yuan per share.

details of the lifting of the ban on the restricted shares of tax friends

in addition, 10 companies with more than 50% of the total share capital lifted this week are weigao orthopedics, tax friends, baiyang medicine, leiwei (301016.SZ), rising stock (836717.BJ), Hangzhou thermoelectric, suyu civilian (301017.SZ), yuekang pharmaceutical (688658.SH), liyuanheng (688499.SH), shenghua (6053).

the number of companies that lifted the ban was more than double the number of shares outstanding before the lifting of the ban, a total of 14 companies. In addition to the above 10, there are core-to-core (688582.SH), Renxin New Material (301395.SZ), Xinke Mobile-U, and Shichuang Energy (688429.SH). Due to the large increase in the number of shares in circulation, the lifting of the ban on restricted shares of such companies has a relatively large impact on their own share prices.

from the type of shares lifted, this week to the first original shareholders restricted shares lifted the ban mainly. Among them, there are 23 original shareholders with restricted shares, 2 initial strategic allotment shares, 6 initial shareholders with restricted shares and initial strategic allotment shares, 2 initial institutional allotment shares, 10 private placement institutions, 13 equity incentive restricted shares, 4 equity incentive general shares, 1 additional commitment restricted shares listed and circulated, and 1 other type.

View original 29K